← Back to Clinical Trials
Recruiting NCT06477965

NCT06477965 Embo Registry; National Registry for Artery Embolization

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06477965
Status Recruiting
Phase
Sponsor Vascular Solutions of North Carolina
Condition Chronic Pain
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2024-07-15
Primary Completion 2027-07-15

Trial Parameters

Condition Chronic Pain
Sponsor Vascular Solutions of North Carolina
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-07-15
Completion 2027-07-15
Interventions
Artery Embolization

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Embo Registry is a retrospective and prospective observational study to evaluate real world effectiveness and the use of Artery Embolization as a treatment for chronic pain with patients that have osteoarthritis and localized pain to provide symptomatic relief. This study is to determine the efficacy and validity of procedure and that following procedure patients had decreased pain and improved quality of life.

Eligibility Criteria

Inclusion Criteria: * \> 18 years of age undergone artery embolization interventions for the treatment of chronic pain due to osteoarthritis or other diagnoses that cause localized pain. Exclusion Criteria: * None

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology